Sampson Lau

Sampson Lau (刘彦燊) is an accomplished finance professional with extensive experience in investment and business development within the pharmaceutical and life sciences sectors. Currently serving as the Director of Investment and Business Development at China Medical System Holdings Ltd since July 2021, Sampson focuses on creating collaboration, investment, and licensing opportunities in the innovative specialty pharma landscape. Previously held positions include Vice President at Delos Capital, where efforts centered on venture capital funding for life sciences innovations, and Vice President at Great Wall WL Ross, specializing in private equity investments. Additionally, Sampson has made personal investments in biotech companies, served as an Associate at a private equity and financial advisory firm, and held analytical roles at Alibaba.com and the Royal Bank of Scotland. Sampson completed a Bachelor of Arts in Economics at the University of Chicago in 2011.